Search research articles
Contact Us
Filters
Showing results (141-150 of 255) with videos related to
Page
of 26
Sort By:
Neurochemical Research
|
July 1, 1980
Titration of human brain type-B monoamine oxidase
C J Fowler, A Wiberg, L Oreland, et al.
Neurochemistry International
|
February 14, 1998
Inhibitors of catecholamine metabolizing enzymes cause changes in S-adenosylmethionine and S-adenosylhomocysteine in the rat brain
M S Yassin, H Cheng, J Ekblom, et al.
Acta Psychiatrica Scandinavica
|
October 1, 1988
Low B12 levels related to high activity of platelet MAO in patients with dementia disorders. A retrospective study
B Regland, C G Gottfries, L Oreland, et al.
Addictive Behaviors
|
January 1, 1991
Personality traits and platelet monoamine oxidase activity in alcoholic women
J Hallman, L von Knorring, G Edman, et al.
Life Sciences
|
September 18, 1998
Autoradiographic imaging of formaldehyde adducts in mice: possible relevance for vascular damage in diabetes
J L Grönvall, H Garpenstrand, L Oreland, et al.
Brain Research
|
April 20, 2001
Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry
J Harro, M Tõnissaar, M Eller, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 10, 2000
Platelet monoamine oxidase activity is related to MAOB intron 13 genotype
H Garpenstrand, J Ekblom, K Forslund, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1996
Influence of vitamin B12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's type
C Gomes-Trolin, C G Gottfries, B Regland, et al.
European Journal of Nuclear Medicine
|
January 1, 1990
Effect of reserpine on the brain uptake of carbon 11 methamphetamine and its N-propagyl derivative, deprenyl
O Inoue, S Axelsson, H Lundqvist, et al.
Lakartidningen
|
February 8, 1995
[Neuropeptide antagonists. Drugs for the year 2000]
R Håkanson, L Oreland, Z Wiesenfeld-Hallin, et al.
Page
of 26
Search research articles
Search
Showing results (141-150 of 255) with videos related to
Sort By:
Page
of 26
Neurochemical Research
|
July 1, 1980
Titration of human brain type-B monoamine oxidase
C J Fowler, A Wiberg, L Oreland, et al.
Neurochemistry International
|
February 14, 1998
Inhibitors of catecholamine metabolizing enzymes cause changes in S-adenosylmethionine and S-adenosylhomocysteine in the rat brain
M S Yassin, H Cheng, J Ekblom, et al.
Acta Psychiatrica Scandinavica
|
October 1, 1988
Low B12 levels related to high activity of platelet MAO in patients with dementia disorders. A retrospective study
B Regland, C G Gottfries, L Oreland, et al.
Addictive Behaviors
|
January 1, 1991
Personality traits and platelet monoamine oxidase activity in alcoholic women
J Hallman, L von Knorring, G Edman, et al.
Life Sciences
|
September 18, 1998
Autoradiographic imaging of formaldehyde adducts in mice: possible relevance for vascular damage in diabetes
J L Grönvall, H Garpenstrand, L Oreland, et al.
Brain Research
|
April 20, 2001
Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry
J Harro, M Tõnissaar, M Eller, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 10, 2000
Platelet monoamine oxidase activity is related to MAOB intron 13 genotype
H Garpenstrand, J Ekblom, K Forslund, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1996
Influence of vitamin B12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's type
C Gomes-Trolin, C G Gottfries, B Regland, et al.
European Journal of Nuclear Medicine
|
January 1, 1990
Effect of reserpine on the brain uptake of carbon 11 methamphetamine and its N-propagyl derivative, deprenyl
O Inoue, S Axelsson, H Lundqvist, et al.
Lakartidningen
|
February 8, 1995
[Neuropeptide antagonists. Drugs for the year 2000]
R Håkanson, L Oreland, Z Wiesenfeld-Hallin, et al.
Page
of 26